Safety and Efficacy of CD19 CAR-T/CAR-NK Cells
Clinical trial NCT06596057 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06596057
- Sponsor
- The Second Hospital of Shandong University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-10
- Primary completion
- 2026-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.